Iomab-B
Actinium Pharmaceuticals
['sierra ']
actinium announces positive pivotal phase 3 sierra trial results in an oral presentation at the eha 2023 congress - health stocks hub $atnm 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2